Kevin A. Thomas is a renowned AI expert who has made significant contributions in the field of medical imaging biomarkers. He is a Co-Founder of Saliency, a Silicon Valley-based startup, which was acquired by Clario in 2020. He currently serves as Clario's Director of AI, where he leverages his extensive expertise in machine learning and biomechanics to drive innovation within the organization. Kevin is also a researcher at Stanford University's Neuromuscular Biomechanics Lab, where he conducts cutting-edge research using AI to gain a better understanding of musculoskeletal diseases.

Kevin earned his Bachelor of Science in Biomedical Engineering Summa Cum Laude from Arizona State University and completed the first two years of Medical School at Stanford University School of Medicine. He also holds a Ph.D. in Biomedical Informatics from Stanford University, where he conducted groundbreaking research that has contributed to the development of AI technologies within the field of medical imaging.

Throughout his career, Kevin has worked with several notable organizations, including Adidas, Philadelphia Phillies, and EXOS, to help advance their machine learning and biomechanics capabilities. He has also held several leadership positions, including Quantitative Analyst Intern at Philadelphia Phillies, Performance Innovation Intern at EXOS, and Leader of Undergraduate Research at ASU Biomechanics Laboratory.

Overall, Kevin's impressive background, expertise, and dedication have contributed significantly to the advancement of AI in the medical field, and he continues to be a driving force in the industry.